SHP Wealth Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
SHP Wealth Management's RPRX Position: Q3 2026 in Review
SHP Wealth Management held its Royalty Pharma (RPRX) position steady in Q3 2026 at 30 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1449.
SHP Wealth Management first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.67K in Q2 2026. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- SHP Wealth Management held 30 shares of Royalty Pharma worth $1.67K as of Q3 2026.
- SHP Wealth Management left its Royalty Pharma share count unchanged in Q3 2026.
- Royalty Pharma made up ﹤0.01% of SHP Wealth Management's portfolio in Q3 2026, its #1449 holding.
- SHP Wealth Management first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
- SHP Wealth Management's Royalty Pharma position peaked at $1.67K in Q2 2026.
- 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on SHP Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.